About MaryRose Cusimano-Reaston, Ph.D.
Form D filings for Emerge Diagnostics from 2020 to 2021 list MaryRose Cusimano-Reaston, Ph.D. as president and CEO.
MaryRose Cusimano-Reaston, Ph.D. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name MaryRose Cusimano-Reaston, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people MaryRose Cusimano-Reaston, Ph.D. works with at each company, as listed on that company's latest Form D.
Emerge Diagnostics, Inc. · Form D, Mar 3, 2021
TW
Thomas Webster
Director
MS
Mark Sampson
Director
GW
Greer Woodruff
Director
MC
Michael Connor
Director
RT
Robert Thompson
Director
ML
Murray Lappe
Director
PR
Phil Reaston
Executive officer